‘Ozempic Santa’: Musk Reveals His Use Of Mounjaro In Latest Weight-Loss Drug Endorsement
What’s The Difference Between Mounjaro And Ozempic? Mounjaro and Ozempic can both help with weight loss but are specifically designated to lower blood sugar in adults with type
Lean-looking Elon Musk reveals he’s taking Mounjaro for weight loss in festive ‘Ozempic Santa’ post
A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar weight-loss drugs as a means to curb America’s obesity epidemic.
Musk upgrades to Mounjaro, 'King Kong' of weight-loss medications
Mounjaro, which has been dubbed the "King Kong" of weight-loss drugs, is considered more effective than its competitors with fewer side effects. It received FDA approval for weight loss in November 2023 under the brand name Zepbound. In the UK, the drug will be available on a limited basis through the NHS starting in April.
Elon Musk reveals recent weight loss due to Mounjaro
Tesla CEO Elon Musk took to his social media platform X to unveil his most recent weight loss while using a blood sugar medication. Musk has increasingly entered the public eye since endorsing President-elect Donald Trump ahead of the Nov.
Elon Musk Shows Off His Mounjaro-Fueled Slimdown — in a Santa Suit
Elon Musk showed off a slender figure on social media while wearing a Santa suit, revealing that he used Mounjaro to achieve his noticeable weight loss.
Game-Changer for Obesity: Weight Loss Drug Mounjaro Set to Launch in India by 2025
Discover how Mounjaro the revolutionary weight-loss and diabetes drug by Eli Lilly is set to transform obesity management in India with its 2025 launch
Elon Musk Reveals He Lost Weight While Taking Mounjaro
Elon Musk posted a photo with the caption "Ozempic Santa" and revealed that he's taking Mounjaro for weight loss. Musk, who Donald Trump appointed to advise him on cutting government spending, has struggled with his weight.
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for these medications.
Elon Musk's Controversial Weight Loss Admission with Mounjaro
New controversy for Elon Musk. With a photo posted on X, the head of Tesla admitted to using medications to lose weight. Posting a picture of himself dressed as Santa Claus, the billionaire
Elon Musk reveals using Mounjaro for weight loss over Ozempic in 'Ozempic Santa' post
A slimmer Elon Musk revealed on Wednesday that he uses Mounjaro, a weight-loss drug, after previously advocating for similar medications as a way to address America’s obesity crisis.
Elon Musk admits he takes the Ozempic-like weight loss drug that RFK Jr. wants to restrict
This holiday season, Elon Musk is calling himself “Ozempic Santa.” Adorned in a Santa Suit on a photo posted to X, The Tesla founder indicates he’s taking one of the widely popular weight loss drugs,
FDA keeps Mounjaro off shortage list after reevaluation
The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a ...
Healthline8d
Mounjaro Interactions: Alcohol, Medications, and Others
Mounjaro (tirzepatide) has potential interactions with other medications and some supplements. For example, Mounjaro can interact with Adderall and oral birth control. An interaction can occur ...
'Such A Better Life': Jim Gaffigan Opens Up About Shedding 50 Lbs On 'The View' After Taking Mounjaro
Jim Gaffigan opened up about shedding 50 pounds on The View, sharing a moment with co-host Whoopi Goldberg as they discussed ...
Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod
Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after ...